Product Information
INDERAL XL 120 MG CAPSULE is a brand product labeled by ANI Pharmaceuticals, Inc., priced at $69.2870 per EA under NDC 62559060130. Its NADAC has been published 124 times since Jul 11, 2018.
FDA first approved this application on Mar 12, 2003. Its Orange Book therapeutic-equivalence code is BX.
The High Outlier badge above means this manufacturer's average price in the propranolol hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
120 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559060130
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
PROPRANOLOL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021438FDA Approved
3/12/2003
TE Code
BX
On Market Since
2/22/2018
Pharmacological Classes
Price Statistics
The NADAC for INDERAL XL 120 MG CAPSULE has been published 124 times since Jul 11, 2018, and over the history we have for it it has risen 185.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $69.2870 per EA |
|---|---|
| All-time high | $69.2870 (Aug 19, 2026) |
| All-time low | $24.3044 (Jul 11, 2018) |
| 52-week high | $69.2870 |
| 52-week low | $69.2870 |
| Median price | $69.2870 |
| Average price | $68.7266 |
| Largest weekly change | +183.3% (Apr 17, 2024) |
| Weeks tracked | 124 |
| Tracking since | Jul 11, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INDERAL XL 120 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for INDERAL XL 120 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $69.2870 per EA (NDC 62559060130), effective Aug 19, 2026.
How has the price of INDERAL XL 120 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for INDERAL XL 120 MG CAPSULE has risen 185.1%. It has been tracked across 124 weekly CMS publications since Jul 11, 2018.
What are the highest and lowest recorded NADAC prices for INDERAL XL 120 MG CAPSULE?
Since Jul 11, 2018, the NADAC for INDERAL XL 120 MG CAPSULE has ranged from a low of $24.3044 (Jul 11, 2018) to a high of $69.2870 (Aug 19, 2026), with a median of $69.2870 per EA.
Are there cheaper alternatives to INDERAL XL 120 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROPRANOLOL ER 120 MG CAPSULE, is $0.1839 per EA — about 99% below INDERAL XL 120 MG CAPSULE.
Who manufactures INDERAL XL 120 MG CAPSULE?
INDERAL XL 120 MG CAPSULE (NDC 62559060130) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a brand product.